Octavio Espinoza - 05 Dec 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
Issuer symbol
LGND
Transactions as of
05 Dec 2023
Net transactions value
-$75,645
Form type
4
Filing time
06 Dec 2023, 15:27:25 UTC
Previous filing
03 Oct 2023
Next filing
16 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $75,645 -1,269 -5.3% $59.61 22,902 05 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.